An ideal thrombolytic and antithrombotic agent?
Matsuo
O
O
Department of Physiology, Kinki University School of Medicine, Oonohigashi, Osakasayama, Japan. matsuo-o@med.kindai.ac.jp
D016503:Drug Delivery Systems; D015195:Drug Design; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008666:Metalloendopeptidases / Q000494:pharmacology / Q000627:therapeutic use; D013923:Thromboembolism / Q000188:drug therapy; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000494:pharmacology / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D008666:Metalloendopeptidases; C022653:auR protein, Staphylococcus aureus